Moreover, by studying a different validation cohort, the authors could confirm and extend these results, by calculating a positive correlation between NSUN5 hypermethylation and progression-free survival in both low grade gliomas and in glioblastomas. This evidence concerns the gene NSUN5 and glioblastoma.